|

Somatostatin analog Clinical Trials

2 actively recruiting trials

Also known as: lanreotide, octreotide, sandostatin, somatuline

Pipeline

Phase 4: 1Phase 2/3: 1

Top Sponsors

  • University Hospital, Antwerp1
  • The Netherlands Cancer Institute1

Indications

  • Cancer2
  • Gastroenteropancreatic Neuroendocrine Tumor1
  • Neuroendocrine Neoplasm1
  • Neuroendocrine Tumor Grade 21
  • Neuroendocrine Tumor Grade 11

Other2 trials

Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
Phase 2/3
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.